Kadmon
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Kadmon and buy or sell other stocks, ETFs, and their options commission-free!About KDMN
Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics to address unmet medical need. The company's clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.
CEOGustavo J. Pesquin, MBA
CEOGustavo J. Pesquin, MBA
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2010
Founded2010
Employees—
Employees—
KDMN Key Statistics
Market cap581.01M
Market cap581.01M
Price-Earnings ratio-3.63
Price-Earnings ratio-3.63
Dividend yield—
Dividend yield—
Average volume1.98M
Average volume1.98M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.50
52 Week high$5.50
52 Week low$2.30
52 Week low$2.30
Stock Snapshot
The current Kadmon(KDMN) stock price is $9.50, with a market capitalization of 581.01M. The stock trades at a price-to-earnings (P/E) ratio of -3.63.
On 2025-12-22, Kadmon(KDMN) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.98M.
Over the past 52 weeks, Kadmon(KDMN) stock has traded between a high of $5.50 and a low of $2.30.
Over the past 52 weeks, Kadmon(KDMN) stock has traded between a high of $5.50 and a low of $2.30.
People also own
Based on the portfolios of people who own KDMN. This list is generated using Robinhood data, and it’s not a recommendation.